Endovascular treatment of acquired atheromatous aortic arch coarctation  by Kische, Stephan et al.
From
th
S.K.
Auth
Rep
og
Be
The
to
an
2352
Cop
So
BY
3.
httpEndovascular treatment of acquired atheromatous
aortic arch coarctation
Stephan Kische, MD, PhD, Giuseppe D’Ancona, MD, PhD, Jasmin Ortak, MD, PhD,
Yannik Stoeckicht, MD, and Hüseyin Ince, MD, PhD, Berlin and Rostock, Germany
Acquired aortic coarctation is a rare condition. Its treatment using a percutaneous approach can be challenging, especially
when severe calciﬁcations and concomitant aneurysmal disease are present. We report a patient with symptomatic thoracic
aorta acquired coarctation and aneurysm that was successfully treated using endovascular technique. After left subclavian
artery transposition, a self-expanding endograft was implanted percutaneously, with complete abolishment of the
transaortic gradient. Follow-up evaluation at 12 months revealed perfect position of the endograft, persistent reduction
of the coarctation, and exclusion of the concomitant aneurysm. A noninvasive pressure reading demonstrated signiﬁcant
systemic blood pressure reduction, with no change in antihypertensive medications. (J Vasc Surg Cases 2015;1:3-5.)Acquired aortic coarctation is a rare condition,1,2 and
the term refers to noncongenital obstructive lesions of
the thoracic aorta producing brachiocephalic hypertension
and relative hypotension in the lower half of the body. The
etiology and anatomical variants of this condition are
heterogeneous. One subgroup comprises patients with
symptomatic focal obstructive calciﬁed lesions of the aorta.
These patients should be differentiated from those present-
ing with congenital aortic narrowing and superimposed
acquired atheromatous calciﬁed thrombi.
When severe aortic calciﬁcations and aneurysm are pre-
sent, percutaneous treatment can be challenging.3 We report
a patient with acquired symptomatic coarctation accompa-
nied by aneurysm formation that was successfully treated us-
ing an endovascular approach. The patient consented to
personal data handling, including clinical case publication.
CASE REPORT
A 65-year-old woman was admitted to the emergency depart-
ment for a hypertensive crisis resulting in dizziness, severe head-
aches, and left arm discomfort. Her past medical history included
hypercholesterolemia, type 2 diabetes mellitus, moderate renal
impairment, and severe chronic obstructive pulmonary disease
(Global Initiative for Chronic Obstructive Lung Disease III).
Her present medical history was notable for onset of arterial hyper-
tension, within the last 6 months, that was poorly controlled by athe Vivantes Klinikum im Friedrichshain und Am Urban, Berlin; and
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://dx.doi.org/10.1016/j.jvsc.2014.09.001combination of two antihypertensive drugs. At physical
examination, a 2/6 systolic heart murmur was present over the
second left intercostal space. In addition, a difference of 50 mm
Hg was noticed between the right and left arm blood pressures.
Results of a 12-lead electrocardiogram and transthoracic echo-
cardiography were within normal limits, without any sign of
myocardial ischemia, left ventricular dysfunction, or hypertrophy.
Results of routine blood analysis were also unremarkable.
To elucidate the vascular anatomy, we performed magnetic
resonance angiography of the thoracic aorta and neck vessels. A
severe aortic coarctation was noticed between the left subclavian
and the left common carotid artery. Immediately after the coarc-
tation, the aorta had developed a convoluted aneurysm, proximal
to the origin of the left subclavian artery (Fig 1, A). A computed
tomography (CT) scan was performed to better clarify the anat-
omy of the lesion and its relationship with the neck vessels and
thoracic organs (Fig 1, B-E). Particular attention was given to
the degree and distribution of calciﬁcations to guide any possible
operative approach. CT imaging demonstrated a localized calci-
ﬁed plaque circumferentially protruding >5 mm within the aortic
lumen. The overall extension of aortic calciﬁcations measured 6
cm (Fig 1, B-E). The remaining aorta appeared within normal
limits. In particular, no collateral circulation originating before
the coarctation and revascularizing the lower part of the body
was noticed. An invasive diagnostic workup, performed through
right radial and femoral artery access, revealed normal coronary
arteries and a systolic pressure gradient of 55 mm Hg across
the coarctation.
In consideration of the signiﬁcant risk of embolization from the
atheromatous aortic arch, the patient was prescribed high-dose sim-
vastatin, and a multidisciplinary discussion was held to investigate
possible treatment strategies of the acquired aortic coarctation.
In light of the increased operative risk derived by her complex
comorbid proﬁle (Society of Thoracic Surgeons Score, 24%), the pa-
tient was referred for a minimally invasive percutaneous approach
and consented to the procedure. In a ﬁrst stage, a subclavian artery
transposition was performed to avoid its unprotected coverage.
In a second phase, within the same hospitalization, a 24-mm
Valiant thoracic endoprosthesis (Medtronic, Minneapolis, Minn)
was implanted via transfemoral access. The procedure was per-
formed in a hybrid suite with surgical backup to manage3
Fig 1. A, Three-dimensional magnetic resonance image shows severe stenosis of the arch (black arrow) distal to the left
common carotid artery (LCCA) with a concomitant aneurysm in close vicinity to the aortic obstruction. B, Three-
dimensional reconstruction from an electrocardiogram-gated computed tomography (CT) conﬁrms extensive calciﬁca-
tion within the middle-distal arch. C, The accompanying aneurysm presents with an irregular shape. Virtual angioscopy
depicts the target lesion as viewed from the ascending aorta, thus demonstrating a calciﬁed subocclusive plug proximal to
the origin of the left subclavian artery (LSA). The white arrows indicate the unaffected ostia of the brachiocephalic trunk
(TBC) and the LCCA. The spatial relations between the intraluminal calciﬁcation, the poststenotic aneurysm (black ar-
rows), and the supraaortic branches are further clariﬁed by (D) a virtually sketched view and by (E) the axial slices.
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advanced across the arch to prevent atherosclerotic debris embo-
lism and was deployed under rapid ventricular pacing.
Immediately after release, a residual stenosis was noticed with
a persistent transaortic gradient of 30 mm Hg. At this stage, a pro-
gressive stent-protected postdilatation of the endoprosthesis was
performed, under rapid ventricular pacing and using noncompliant
8-mm and 10 mm Tyshak-X (NuMed, Hopkinton, NY) and 14-
mm Maxi-LD (Cordis, Bridgewater, NJ) balloons. Although a re-
sidual stenosis was present, the transcoarctation gradient was ﬁnally
reduced to 0 mm Hg, and the poststenotic convoluted aneurysm
was completely excluded.
The patient’s postoperative course was uneventful, and she
was discharged home within a week. A 12-month follow-up CT
scan conﬁrmed a perfect position of the endoprosthesis, drastic
and persistent reduction of the aortic coarctation degree, and
exclusion of the concomitant aneurysm (Fig 2). A 24-hour nonin-
vasive pressure reading demonstrated signiﬁcant reduction of sys-
temic blood pressure with dual-antihypertensive therapy.
DISCUSSION
Acquired aortic coarctation is rare, and its etiology is
often related to atherosclerosis.4 The evolution of the
lesion is normally slow, allowing for compensatory ventric-
ular hypertrophy and development of collateral circulation
to vascularize the distal body. When severe calciﬁcations
are present within the coarctation and in the borderingsegments of aorta, the macroscopic image resembles a coral
reef.5,6 In this condition, treatment of the coarctation may
be cumbersome as a result of the embolization and rupture
risks.
The patient in the case reported here presents some
peculiarities. First, the origin of the lesion was unclear.
In fact, the sudden onset of symptoms and the complete
absence of compensatory signs to overcome the coarcta-
tion may all suggest an almost subacute evolution. If this
were the case, a different etiology could be hypothesized
to explain the rapid evolution of the coarctation. Whether
the lesion was of atherosclerotic or other origin (infective,
inﬂammatory) cannot be answered from the collected
information.
Second, the location of the lesion is also unusual. In
fact, most acquired coarctations are postisthmic.5,7 In this
particular case, the stenosis was located immediately before
the origin of the left subclavian artery.
Finally, the treatment that we selected was not conven-
tional for this type of pathology. Although percutaneous
treatment of acquired aortic coarctation has been pro-
posed,8,9 management of such a heavily calciﬁed and com-
plex lesion can be treacherous. Conventional surgery
should be advocated for most patients, especially when
the expertise in percutaneous treatment of such complex
cases is not available.5,10 The risks of endovascular treat-
ment include embolization of calciﬁed debris, iatrogenic
Fig 2. Follow-up computed tomography (CT) scan shows the thoracic aorta anatomy 12 months after endovascular
repair of the acquired aortic coarctation. A, A three-dimensional reconstruction shows the endoprosthesis within the
distal aortic arch. To avoid unprotected side branch coverage, a left subclavian artery (LSA) transposition was per-
formed before the endoprosthesis placement (black arrow). B, Discrete residual compression of the proximal stent by
compact calciﬁed debris (white arrows) is displayed in a cross-sectional plane and (C) further clariﬁed by a virtual
angioscopy. D, Note that the obstructed lumen has been adequately reconstructed with exclusion of the convoluted
poststenotic aneurysm (*).
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neous strategy is planned, two important goals should be
achieved. First, the immediate and direct trauma within
the aorta should be minimized, reaching progressively the
desired pressure gradient reduction. Second, complete
exclusion of the concomitant poststenotic aortic dilatation
should be simultaneously obtained.11
In our experience, a self-expandable covered stent
(endoprostheses) presents the required characteristics to
treat this condition. Its radial force will lead to partial
dilatation of the coarctation and immediate aneurysm
exclusion. A progressive and protected (from the endo-
prostheses fabric) balloon dilatation can be performed
whenever residual aortic stenosis is noticed. In particular,
further dilatation should be aimed mainly at correcting
the transaortic gradient and, for this reason, should be
guided more by the hemodynamic measurements than by
the angiographic imaging.
CONCLUSIONS
Acquired coarctation may result from severe calciﬁca-
tion and atherosclerosis of the aortic wall. Although con-
ventional surgery must be advised in most patients,
tailored endovascular approaches could be proposed. In
this context, when extensive aortic calciﬁcations are pre-
sent, endovascular treatment can be an option, if per-
formed within an adequately experienced environment
and using the appropriate material.12
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